Anderson B V, Tomasulo P A
Florida International University, Medical Laboratory Sciences Department, Miami.
Transfusion. 1988 Jul-Aug;28(4):394-6. doi: 10.1046/j.1537-2995.1988.28488265277.x.
A questionnaire was distributed to 509 AABB institutional members to evaluate current autologous transfusion practices. Results were returned from 47 blood centers, 108 transfusion services and 64 hospital blood banks (response rate 43%). Results indicate that not all eligible patients are allowed to donate due to unnecessarily strict eligibility criteria. Thirty percent of autologous units are not tested for infectious disease markers. Of those units tested and found positive for anti-HIV or HBsAg, 53 and 72% respectively, of the institutions provide the units to the intended recipient. Forty-seven percent of institutions perform an AHG crossmatch for autologous recipients. Sixty five percent of institutions permit "crossing-over" of autologous units for homologous use. Implications of these findings for the development of standards for autologous transfusion programs are discussed.
向509名美国血库协会（AABB）机构成员发放了一份调查问卷，以评估当前的自体输血实践情况。收到了来自47家血液中心、108家输血服务机构和64家医院血库的回复（回复率为43%）。结果表明，由于不必要的严格资格标准，并非所有符合条件的患者都被允许献血。30%的自体血液单位未进行传染病标志物检测。在那些接受检测且抗HIV或HBsAg呈阳性的单位中，分别有53%和72%的机构将这些单位提供给预定的受血者。47%的机构对自体输血受血者进行抗人球蛋白交叉配血试验。65%的机构允许将自体血液单位“交叉使用”于异体输血。讨论了这些发现对自体输血计划标准制定的影响。
